These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23156282)

  • 21. Systemic therapy in metastatic or recurrent endometrial cancer.
    Pectasides D; Pectasides E; Economopoulos T
    Cancer Treat Rev; 2007 Apr; 33(2):177-90. PubMed ID: 17196749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant treatment of early-stage endometrial cancer: which patient can benefit from chemotherapy?
    Eichbaum MH; Sohn C
    Gynecol Oncol; 2008 Jun; 109(3):434; author reply 434-6. PubMed ID: 18295870
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy for high-risk early-stage endometrial cancer.
    Kodama J; Seki N; Hiramatsu Y
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):42-7. PubMed ID: 17218851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy in endometrial cancer.
    Obel JC; Friberg G; Fleming GF
    Clin Adv Hematol Oncol; 2006 Jun; 4(6):459-68. PubMed ID: 16981669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hormonal therapy and chemotherapy of endometrial cancer].
    Krauss T; Huschmand H; Hinney B; Viereck V; Emons G
    Zentralbl Gynakol; 2002 Jan; 124(1):45-50. PubMed ID: 11873314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trials referral resource. Current clinical trials in endometrial cancer.
    Trimble E; Valmonte CM; Cheson BD
    Oncology (Williston Park); 2000 Jun; 14(6):850, 855, 859. PubMed ID: 10887635
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant treatment for stage IIIC endometrial cancer: options and controversies.
    Shah PH; Kudrimoti M; Feddock J; Randall M
    Gynecol Oncol; 2011 Sep; 122(3):675-83. PubMed ID: 21664661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of cancer chemotherapy on patients with recurrent endometrial carcinoma].
    Kakinoki S; Takizawa K
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():365-9. PubMed ID: 15535269
    [No Abstract]   [Full Text] [Related]  

  • 29. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
    Gadducci A; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of chemotherapy in recurrent endometrial carcinoma].
    Wang ZQ; Wang JL; Liu FT; Zhao D; Gao M; Wei LH
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):896-900. PubMed ID: 16759515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy for early stage endometrial cancer? Should we be using it?
    Rodriguez AO
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):1-3. PubMed ID: 18196997
    [No Abstract]   [Full Text] [Related]  

  • 32. [Successful treatment of endometrial carcinoma associated with lung metastasis by paclitaxel and carboplatin chemotherapy].
    Tohya T; Onoda C; Yoshimura T; Kagami T
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):949-51. PubMed ID: 15222119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Update on postoperative chemotherapy for endometrial cancer].
    Tsujioka H; Hachisuga T; Kawarabayashi T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():351-5. PubMed ID: 15535266
    [No Abstract]   [Full Text] [Related]  

  • 34. Does the progression-free interval after primary chemotherapy predict survival after salvage chemotherapy in advanced and recurrent endometrial cancer?: a Gynecologic Oncology Group ancillary data analysis.
    Moore KN; Tian C; McMeekin DS; Thigpen JT; Randall ME; Gallion HH
    Cancer; 2010 Dec; 116(23):5407-14. PubMed ID: 20737572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recent outline of chemotherapy for uterine endometrial cancer].
    Watanabe Y; Hoshiai H
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():346-50. PubMed ID: 15535265
    [No Abstract]   [Full Text] [Related]  

  • 36. Resistance to chemotherapy and hormone therapy in endometrial cancer.
    Chaudhry P; Asselin E
    Endocr Relat Cancer; 2009 Jun; 16(2):363-80. PubMed ID: 19190080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal treatment of endometrial cancer: past, present and future.
    Podczaski E; Mortel R
    Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):469-89. PubMed ID: 11476566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic therapy for recurrent endometrial cancer: a review of North American trials.
    Dellinger TH; Monk BJ
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):905-16. PubMed ID: 19589030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A feasibility study of carboplatin and weekly paclitaxel combination chemotherapy in endometrial cancer: a Kansai Clinical Oncology Group study (KCOG0015 trial).
    Ito K; Tsubamoto H; Itani Y; Kuroboshi H; Fujita H; Nobunaga T; Coleman RL
    Gynecol Oncol; 2011 Feb; 120(2):193-7. PubMed ID: 21075434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination chemotherapy with paclitaxel and carboplatin (TC therapy) for endometrial cancer].
    Misawa A; Nagao M; Kushimoto T; Yasuda M
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1901-5. PubMed ID: 19011339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.